C

Castle Biosciences
D

CSTL

25.730
USD
-0.43
(-1.64%)
Market Closed
Volume
13,614
EPS
-2
Div Yield
-
P/E
123
Market Cap
720,627,855
OverviewSignalsIdeasNews
Related Instruments
    CL
    CL
    1.604
    (1.83%)
    89.474 USD
    C
    CLX
    4.220
    (2.76%)
    157.300 USD
    C
    CPB
    1.240
    (3.15%)
    40.580 USD
    HSY
    HSY
    6.790
    (4.09%)
    172.980 USD
    KHC
    KHC
    0.985
    (3.27%)
    31.140 USD
    KMB
    KMB
    1.300
    (0.94%)
    140.280 USD
    MKC
    MKC
    0.950
    (1.20%)
    80.150 USD
    N
    NWL
    -0.02000
    (-0.29%)
    6.79500 USD
    PG
    PG
    3.000
    (1.79%)
    170.240 USD
    More
News

Title: Castle Biosciences

Sector: Healthcare
Industry: Diagnostics & Research
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.